Annual EBITDA
-$47.37 M
-$1.68 M-3.68%
December 31, 2023
Summary
- As of February 7, 2025, SPRB annual EBITDA is -$47.37 million, with the most recent change of -$1.68 million (-3.68%) on December 31, 2023.
- During the last 3 years, SPRB annual EBITDA has fallen by -$18.19 million (-62.32%).
- SPRB annual EBITDA is now -380.53% below its all-time high of -$9.86 million, reached on December 31, 2018.
Performance
SPRB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$8.59 M
+$496.00 K+5.46%
September 30, 2024
Summary
- As of February 7, 2025, SPRB quarterly EBITDA is -$8.59 million, with the most recent change of +$496.00 thousand (+5.46%) on September 30, 2024.
- Over the past year, SPRB quarterly EBITDA has increased by +$1.24 million (+12.60%).
- SPRB quarterly EBITDA is now -237.66% below its all-time high of -$2.54 million, reached on September 30, 2019.
Performance
SPRB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$39.02 M
+$3.63 M+8.51%
September 30, 2024
Summary
- As of February 7, 2025, SPRB TTM EBITDA is -$39.02 million, with the most recent change of +$3.63 million (+8.51%) on September 30, 2024.
- Over the past year, SPRB TTM EBITDA has increased by +$8.35 million (+17.63%).
- SPRB TTM EBITDA is now -1433.69% below its all-time high of -$2.54 million, reached on September 30, 2019.
Performance
SPRB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SPRB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.7% | +12.6% | +17.6% |
| 3 y3 years | -62.3% | +12.6% | +17.6% |
| 5 y5 years | -380.5% | +12.6% | +17.6% |
SPRB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.1% | at low | at high | +32.3% | at high | +19.6% |
| 5 y | 5-year | -264.1% | at low | -175.9% | +32.3% | -589.7% | +19.6% |
| alltime | all time | -380.5% | at low | -237.7% | +32.3% | -1433.7% | +19.6% |
Spruce Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.59 M(-5.5%) | -$39.02 M(-8.5%) |
| Jun 2024 | - | -$9.09 M(-21.1%) | -$42.65 M(-7.8%) |
| Mar 2024 | - | -$11.51 M(+17.1%) | -$46.24 M(-2.4%) |
| Dec 2023 | -$47.37 M(+3.7%) | -$9.83 M(-19.6%) | -$47.37 M(-2.4%) |
| Sep 2023 | - | -$12.22 M(-3.6%) | -$48.53 M(+2.0%) |
| Jun 2023 | - | -$12.68 M(+0.3%) | -$47.58 M(+1.9%) |
| Mar 2023 | - | -$12.64 M(+15.0%) | -$46.67 M(+2.2%) |
| Dec 2022 | -$45.69 M(+9.1%) | -$10.99 M(-2.5%) | -$45.69 M(+4.4%) |
| Sep 2022 | - | -$11.27 M(-4.3%) | -$43.77 M(-0.2%) |
| Jun 2022 | - | -$11.77 M(+1.0%) | -$43.84 M(+0.2%) |
| Mar 2022 | - | -$11.65 M(+28.4%) | -$43.75 M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$41.88 M(+43.5%) | -$9.08 M(-20.0%) | -$41.88 M(+2.0%) |
| Sep 2021 | - | -$11.34 M(-2.9%) | -$41.05 M(+4.7%) |
| Jun 2021 | - | -$11.68 M(+19.3%) | -$39.21 M(+15.8%) |
| Mar 2021 | - | -$9.79 M(+18.6%) | -$33.87 M(+16.1%) |
| Dec 2020 | -$29.18 M(+124.3%) | -$8.25 M(-13.2%) | -$29.18 M(+21.4%) |
| Sep 2020 | - | -$9.50 M(+49.9%) | -$24.04 M(+40.7%) |
| Jun 2020 | - | -$6.34 M(+24.4%) | -$17.09 M(+58.9%) |
| Mar 2020 | - | -$5.09 M(+63.6%) | -$10.75 M(+90.0%) |
| Dec 2019 | -$13.01 M(+32.0%) | -$3.11 M(+22.4%) | -$5.66 M(+122.4%) |
| Sep 2019 | - | -$2.54 M | -$2.54 M |
| Dec 2018 | -$9.86 M | - | - |
FAQ
- What is Spruce Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Spruce Biosciences?
- What is Spruce Biosciences annual EBITDA year-on-year change?
- What is Spruce Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Spruce Biosciences?
- What is Spruce Biosciences quarterly EBITDA year-on-year change?
- What is Spruce Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Spruce Biosciences?
- What is Spruce Biosciences TTM EBITDA year-on-year change?
What is Spruce Biosciences annual EBITDA?
The current annual EBITDA of SPRB is -$47.37 M
What is the all time high annual EBITDA for Spruce Biosciences?
Spruce Biosciences all-time high annual EBITDA is -$9.86 M
What is Spruce Biosciences annual EBITDA year-on-year change?
Over the past year, SPRB annual EBITDA has changed by -$1.68 M (-3.68%)
What is Spruce Biosciences quarterly EBITDA?
The current quarterly EBITDA of SPRB is -$8.59 M
What is the all time high quarterly EBITDA for Spruce Biosciences?
Spruce Biosciences all-time high quarterly EBITDA is -$2.54 M
What is Spruce Biosciences quarterly EBITDA year-on-year change?
Over the past year, SPRB quarterly EBITDA has changed by +$1.24 M (+12.60%)
What is Spruce Biosciences TTM EBITDA?
The current TTM EBITDA of SPRB is -$39.02 M
What is the all time high TTM EBITDA for Spruce Biosciences?
Spruce Biosciences all-time high TTM EBITDA is -$2.54 M
What is Spruce Biosciences TTM EBITDA year-on-year change?
Over the past year, SPRB TTM EBITDA has changed by +$8.35 M (+17.63%)